Snowflake Inc. (BMV:SNOW)

Verve Therapeutics Revenue

Snowflake had revenue of $1.04B USD in the quarter ending April 30, 2025, with 25.75% growth. This brings the company's revenue in the last twelve months to $3.84B, up 27.50% year-over-year. In the fiscal year ending January 31, 2025, Snowflake had annual revenue of $3.63B with 29.21% growth.

• Revenue (ttm): $3.84B
• Revenue Growth: +27.50%
• P/S Ratio: 17.21
• Revenue / Employee: $490.14K
• Employees: 7,834
• Market Cap: 1,294.40B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jan 31, 2025	3.63B	819.91M	29.21%
Jan 31, 2024	2.81B	740.83M	35.86%
Jan 31, 2023	2.07B	846.33M	69.41%
Jan 31, 2022	1.22B	627.28M	105.95%
Jan 31, 2021	592.05M	327.30M	123.63%